Bal Pharma Q3 Results

  • BSE: 524824
  • NSE: BALPHARMA
  • ISIN: INE083D01012
  • Sector: Biotechnology & Drugs
BSE
133.2-2.70 (-1.99%)
Volume631.00
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
134.4-2.75 (-2.01%)
Volume5.91 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Today: 133.20
133.20
52-Wk: 89.20
157.90

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bal Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 81.6692.54-%76.62-%
    Selling/ General/ Admin Expenses Total 15.2615.30-%14.06-%
    Depreciation/ Amortization 2.962.42-%2.45-%
    Other Operating Expenses Total 12.7716.23-%11.53-%
    Total Operating Expense 76.8387.26-%72.92-%
    Operating Income 4.835.28-%3.70-%
    Net Income Before Taxes 1.271.60-%1.05-%
    Net Income 0.890.95-%0.57-%
    Diluted Normalized EPS 0.560.62-%0.38-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts